HC Wainwright Lowers Adicet Bio (NASDAQ:ACET) to Neutral

HC Wainwright cut shares of Adicet Bio (NASDAQ:ACET – Free Report) from a buy rating to a neutral rating in a report issued on Wednesday, MarketBeat Ratings reports. A number of other brokerages also recently issued reports on ACET. Wedbush restated an outperform rating and issued a $5.00 price target on shares of Adicet Bio […]

Leave a Reply

Your email address will not be published.

Previous post Jefferies Financial Group Raises AppLovin (NASDAQ:APP) Price Target to $108.00
Next post Apple (NASDAQ:AAPL) Earns “Overweight” Rating from Morgan Stanley